AKAM vs TARS · P/E 27, rev $2.17B vs rev $336.0M
Akamai Technologies Inc (AKAM) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. TARS currently screens at market cap $2.66B.
Not investment advice. Open the AKAM and TARS stock pages for the full models.
Not investment advice.